Mistabron 200 mg solution for Inhalation

About Mistabron 200 mg solution for Inhalation

Mistabron 200 mg solution for inhalation is an essential medication designed to prevent bladder bleeding specifically associated with the chemotherapy agent ifosfamide. This targeted treatment works by forming a protective barrier in the bladder, helping to reduce the risk of bleeding that can occur during cancer therapy. Its important to note that Mistabron is not intended for managing bladder bleeding resulting from other medical conditions. Administration of this solution is carried out by a healthcare professional, ensuring precise dosing tailored to your unique medical needs and response to treatment. Adhering strictly to your doctor's instructions is crucial, as improper use or an overdose of Mistabron may lead to serious health complications. Patients should discuss any concerns or side effects with their healthcare provider to ensure optimal safety and effectiveness. With its specific focus on chemotherapy-related bladder issues, Mistabron plays a vital role in supporting patients undergoing cancer treatment.

Pharmaceutical Class and Usage

Mistabron falls under the mucolytic agent class, primarily prescribed to help patients manage excessive or thick mucus in respiratory conditions. Its liquid form ensures effective administration by inhalation, offering relief for both children and adults. Healthcare providers recommend its use only with a valid prescription to ensure safe and appropriate therapy.


Features and Packaging

Each Mistabron solution is packaged in an amber PET bottle with a tamper-evident cap for enhanced safety and product integrity. The unflavoured formulation makes it suitable for a wide patient population. The product is supplied in quantities of 155 pieces per batch, meeting the needs of distributors and medical facilities. Amber PET enhances shelf stability and the solution can be stored for up to 24 months.